S. Danese, B. Sands, S. Ng, L. Peyrin-Biroulet
Nature Reviews Gastroenterology & Hepatology, 2020
During the coronavirus disease 2019 (COVID-19) pandemic, inflammatory bowel disease (IBD) practices have been disrupted. This Comment summarizes the key strategies that should be implemented for both patients and IBD specialists to provide optimal care while avoiding new outbreaks for the first 6–12 months after the peak of the COVID-19 pandemic.
Cited by 10 publications.
Field of study: Medicine